Dr. Bergink is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1425 Madison Ave # L4-34
New York, NY 10029Phone+1 212-659-1483- Is this information wrong?
Summary
- Dr. Bergink is the director of Mount Sinai’s Women’s Mental Health Program, and is internationally renowned as an expert in the treatment of psychiatric disorders during pregnancy and the postpartum period. She a professor at the Department of Psychiatry and the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai.
Dr. Bergink specializes in mental health stability during pregnancy and the postpartum period, as well as the treatment of bipolar disorder. From 2004 to 2018, she treated patients at Erasmus University hospital in Rotterdam, where she led the Acute Inpatient Unit, the Mother-Baby Unit, and the Center of Excellence in Perinatal Psychiatry. She then moved to New York City to lead Mount Sinai’s Women’s Mental Health Program.
Dr. Bergink has published extensively in top-tier scientific journals. Two papers were listed as top 10 most important clinical studies in in the entire field of psychiatry, selected by the publishing group of the NEJM. She received prestigious awards, such as the price for the best research within all faculty in the last three years at Erasmus University and the Ramaer medal from the Netherlands Psychiatric Association, awarded to the person who contributed the most to the field of clinical and scientific Psychiatry over the last two years.Her work has been funded by various sources such as the NIH, European Union, the Dutch Government, and private foundations.
Education & Training
- University of Groningen Faculty of Medical ScienceClass of 1998
Certifications & Licensure
- NY State Medical License 2019 - 2025
Clinical Trials
- Maternal And Infant Antipsychotic Study Start of enrollment: 2023 Sep 29
Roles: Contact
Publications & Presentations
PubMed
- SARS-CoV-2 infection, inflammation and birth outcomes in a prospective NYC pregnancy cohort.Frederieke A J Gigase, Rebecca H Jessel, Elianna Kaplowitz, Natalie Boychuk, Sophie Ohrn, Erona Ibroci 1st, Juliana Castro, Jezelle Lynch, Rushna Tubassum, Amy Balbier...> ;Journal of Reproductive Immunology. 2024 Mar 18
- Choosing lithium in the perinatal period, lower dose in the first trimester of pregnancy.Veerle Bergink> ;European Neuropsychopharmacology. 2024 Apr 1
- Attention-Deficit Hyperactivity Disorder (ADHD) Medication Use Trajectories Among Women in the Perinatal Period.Kathrine Bang Madsen, Mette Bliddal, Charlotte Borg Skoglund, Henrik Larsson, Trine Munk-Olsen, Malene Galle Madsen, Per Hove Thomsen, Veerle Bergink, Chaitra Srinivas...> ;CNS Drugs. 2024 Apr 1
- Join now to see all
Journal Articles
- Meeting Maternal Mental Health Needs During the COVID-19 PandemicAlison Hermann, Elizabeth M Fitelson, Veerle Bergink, JAMA Psychiatry
Authored Content
- Meeting Maternal Mental Health Needs During the COVID-19 PandemicJuly 2020
- Meeting Maternal Mental Health Needs During the COVID-19 PandemicJuly 2020
- Meeting Maternal Mental Health Needs During the COVID-19 PandemicJuly 2020
Press Mentions
- What We Still Don’t Understand About Postpartum PsychosisMarch 14th, 2023
- No Sign That ADHD Meds in Pregnancy Can Raise Odds for ADHD, Autism in KidsFebruary 14th, 2023
- Pregnant Women with ADHD Can Breathe a Sigh of ReliefFebruary 13th, 2023
- Join now to see all
Hospital Affiliations
- The Mount Sinai HospitalNew York, New York
- Mount Sinai Beth IsraelNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: